Peress Investment Advisors »

Sage Therapeutics shares owned by Peress Investment Advisors

Quarter-by-quarter ownership of Sage Therapeutics (SAGE) shares owned by Peress Investment Advisors from 13F filings

Historical chart of Peress Investment Advisors investment in Sage Therapeutics

Tip: Access up to 7 years of quarterly data

All positions including Sage Therapeutics held by Peress Investment Advisors consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Sage Therapeutics by Peress Investment Advisors

Quarter filed Position value Share count Share price at filing
2018-06-30 $1.3M 8.1k 156.52

More positions owned by Peress Investment Advisors

Intuit (INTU)
Texas Instruments Incorporated (TXN)
Adobe Systems Incorporated (ADBE)
Vanguard Total Stock Market ETF (VTI)
Dominion Resources (D)
Berkshire Hathaway (BRK.B)
FedEx Corporation (FDX)
Biogen Idec (BIIB)
CBOE Holdings (CBOE)
Vanguard Balanced Indx (VBINX)
United Technologies Corporation
Dowdupont
Unilever
Cme (CME)
Costco Wholesale Corporation (COST)

View all positions for Peress Investment Advisors

Top funds holding Sage Therapeutics

Wellington Management Company
Vanguard Group
Bellevue Group
Jpmorgan Chase & Co
Cowen And Company
Deutsche Bank Aktiengesellschaft
Palo Alto Investors
Dimensional Fund Advisors
Samlyn Capital
Jacobs Levy Equity Management
Citadel Advisors
T. Rowe Price Associates
Goldman Sachs Group
Fisher Investments
Charles Schwab Investment Management

View all funds holding Sage Therapeutics